An obligatory role for club cells in preventing obliterative bronchiolitis in lung transplants.
Animals
Bronchioles
/ cytology
Bronchiolitis Obliterans
/ immunology
CD8-Positive T-Lymphocytes
/ immunology
Cells, Cultured
Coculture Techniques
Disease Models, Animal
Epithelial Cells
/ immunology
Graft Rejection
/ immunology
Humans
Lung Transplantation
/ adverse effects
Mice
Primary Cell Culture
Respiratory Mucosa
/ cytology
Transplantation, Homologous
/ adverse effects
Immunology
Organ transplantation
Transplantation
Journal
JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073
Informations de publication
Date de publication:
16 04 2019
16 04 2019
Historique:
entrez:
17
4
2019
pubmed:
17
4
2019
medline:
25
9
2020
Statut:
epublish
Résumé
Obliterative bronchiolitis (OB) is a poorly understood airway disease characterized by the generation of fibrotic bronchiolar occlusions. In the lung transplant setting, OB is a pathological manifestation of bronchiolitis obliterans syndrome (BOS), which is a major impediment to long-term recipient survival. Club cells play a key role in bronchiolar epithelial repair, but whether they promote lung transplant tolerance through preventing OB remains unclear. We determined if OB occurs in mouse orthotopic lung transplants following conditional transgene-targeted club cell depletion. In syngeneic lung transplants club cell depletion leads to transient epithelial injury followed by rapid club cell-mediated repair. In contrast, allogeneic lung transplants develop severe OB lesions and poorly regenerate club cells despite immunosuppression treatment. Lung allograft club cell ablation also triggers the recognition of alloantigens, and pulmonary restricted self-antigens reported associated with BOS development. However, CD8+ T cell depletion restores club cell reparative responses and prevents OB. In addition, ex-vivo analysis reveals a specific role for alloantigen-primed effector CD8+ T cells in preventing club cell proliferation and maintenance. Taken together, we demonstrate a vital role for club cells in maintaining lung transplant tolerance and propose a new model to identify the underlying mechanisms of OB.
Identifiants
pubmed: 30990794
pii: 124732
doi: 10.1172/jci.insight.124732
pmc: PMC6538316
doi:
pii:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIAID NIH HHS
ID : P01 AI116501
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL121218
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL007317
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI119506
Pays : United States
Références
Nat Med. 1999 Nov;5(11):1303-7
pubmed: 10545998
Am J Physiol Lung Cell Mol Physiol. 2000 Jun;278(6):L1256-63
pubmed: 10835332
Transplantation. 2002 Apr 27;73(8):1264-9
pubmed: 11981419
Am J Physiol Lung Cell Mol Physiol. 2002 Dec;283(6):L1315-21
pubmed: 12388377
Nat Immunol. 2002 Dec;3(12):1208-13
pubmed: 12415266
J Immunol. 2002 Nov 15;169(10):5401-4
pubmed: 12421913
Am J Respir Crit Care Med. 2004 Jul 15;170(2):181-7
pubmed: 15130908
Blood. 2004 Nov 15;104(10):3257-66
pubmed: 15284116
Transplantation. 2005 Jul 27;80(2):185-92
pubmed: 16041262
J Clin Invest. 2007 Nov;117(11):3498-506
pubmed: 17965778
J Heart Lung Transplant. 2007 Dec;26(12):1229-42
pubmed: 18096473
J Immunol. 2008 Mar 15;180(6):3910-8
pubmed: 18322199
Am J Respir Cell Mol Biol. 2010 Feb;42(2):161-71
pubmed: 19423773
Clin Exp Immunol. 2009 Nov;158(2):230-6
pubmed: 19737140
Blood. 2010 Apr 15;115(15):2989-97
pubmed: 20103781
Am J Respir Cell Mol Biol. 2011 Jun;44(6):794-803
pubmed: 20656948
Am J Respir Crit Care Med. 2011 Feb 15;183(4):511-21
pubmed: 20870756
Am J Transplant. 2011 Feb;11(2):329-35
pubmed: 21272237
Am J Respir Cell Mol Biol. 2011 Jun;44(6):749-54
pubmed: 21653906
Vet Pathol. 2012 Jan;49(1):32-43
pubmed: 22135019
PLoS One. 2012;7(1):e29802
pubmed: 22238655
Immunology. 2012 Jul;136(3):344-51
pubmed: 22444300
Mucosal Immunol. 2012 Sep;5(5):544-54
pubmed: 22549742
Am J Transplant. 2012 Aug;12(8):2164-71
pubmed: 22568593
Am J Transplant. 2012 Nov;12(11):3076-84
pubmed: 22883104
Transplantation. 2012 Sep 27;94(6):652-8
pubmed: 22902791
Am J Physiol Lung Cell Mol Physiol. 2013 Mar 15;304(6):L401-14
pubmed: 23262228
Am J Transplant. 2013 Mar;13(3):754-9
pubmed: 23331756
J Toxicol Environ Health. 1990 May;30(1):53-67
pubmed: 2348480
Am J Transplant. 2013 Oct;13(10):2540-9
pubmed: 23927673
J Clin Invest. 2014 Mar;124(3):1130-43
pubmed: 24569377
PLoS One. 2014 Feb 21;9(2):e88848
pubmed: 24586412
Am J Transplant. 2014 Apr;14(4):841-8
pubmed: 24666830
J Heart Lung Transplant. 2014 Dec;33(12):1273-81
pubmed: 25130554
J Heart Lung Transplant. 2014 Dec;33(12):1288-94
pubmed: 25443870
Am J Transplant. 2015 Sep;15(9):2324-35
pubmed: 26079467
Am J Transplant. 2016 Jun;16(6):1751-65
pubmed: 26714197
Chest. 2016 Jul;150(1):219-25
pubmed: 27212132
Kardiochir Torakochirurgia Pol. 2016 Mar;13(1):26-30
pubmed: 27212975
J Heart Lung Transplant. 2016 Oct;35(10):1170-1184
pubmed: 27772669
Am J Transplant. 2017 Jun;17(6):1637-1648
pubmed: 27931084
BMJ Open Respir Res. 2017 Apr 12;4(1):e000177
pubmed: 28469930
BMC Pulm Med. 2017 Jul 18;17(1):102
pubmed: 28720146
Am J Transplant. 2018 Jan;18(1):216-225
pubmed: 28730633
Stem Cell Reports. 2017 Dec 12;9(6):1780-1795
pubmed: 29198829
Hum Immunol. 2018 Sep;79(9):653-658
pubmed: 29908844
Nature. 2018 Aug;560(7718):319-324
pubmed: 30069044
J Clin Invest. 2019 Feb 1;129(2):556-568
pubmed: 30561386
JCI Insight. 2019 Feb 7;4(3):
pubmed: 30728330
Am J Respir Cell Mol Biol. 1995 Feb;12(2):205-10
pubmed: 7865218
Am J Physiol. 1995 Dec;269(6 Pt 1):L791-9
pubmed: 8572241
Nature. 1998 Feb 5;391(6667):591-4
pubmed: 9468137